Cargando…
5-α reductase inhibitors and prostate cancer prevention: where do we turn now?
With the lifetime risk of being diagnosed with prostate cancer so great, an effective chemopreventive agent could have a profound impact on the lives of men. Despite decades of searching for such an agent, physicians still do not have an approved drug to offer their patients. In this article, we out...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180399/ https://www.ncbi.nlm.nih.gov/pubmed/21920036 http://dx.doi.org/10.1186/1741-7015-9-105 |